Hello, it looks like you are visiting from United States / Estados Unidos Language US Go to United States (English) / Estados Unidos (español) site

The more you know, the clearer things become.

Confidence through evidence. That's MiYOSMART.

8 Years of Evidence

MiYOSMART is clinically proven to slow down myopia progression, with results sustained over 8 years.1

The MiYOSMART 8-year follow-up study is the longest running myopia management spectacle lens study to date.2

Researched in the UK

In a UK multi-site observational study, MiYOSMART spectacle lenses effectively slowed down myopia progression over 2 years.3

Recognised by the IMI

MiYOSMART has been reported as an effective myopia management option by the International Myopia Institute.4

An estimated 5 billion people, or half the global population, could be affected by myopia by 2050.*

Myopia is a global concern.

Annual myopia progression rate is most rapid under 10 years of age. Significantly greater rates of progression can be seen especially in children with high myopia.

If left untreated, myopia can lead to lasting vision problems, but together we can curb myopia in children.

Last year, HOYA launched its myopia simulator to help parents understand how their child might see the world as myopia progresses. 

experience the myopia simulator

An innovative spectacle lens.

This spectacle lens is based on revolutionary Defocus Incorporated Multiple Segments (D.I.M.S.) Technology. This was developed in collaboration with The Hong Kong Polytechnic University in 2014. MiYOSMART spectacle lenses are easy to fit and look just like a regular single vision lens.

 

In 2018, MiYOSMART spectacle lenses won the Gold Prize, Grand Award & Special Gold Award International Exhibition of Inventions of Geneva, Switzerland. In 2020, they also won the Silmo d’Or Award in the Vision category at the Silmo Paris Optical Fair.

 

The results of a two-year clinical trial showed that daily use of MiYOSMART spectacle lenses slowed down myopia progression on average by 60% compared to wearing standard single vision lenses.5

A revolutionary technology.

With the exclusive non-invasive D.I.M.S. Technology, the lens provides a full vision correction and has a ring shaped treatment zone to slow down myopia progression. The combination of the focus zone and treatment zone provides clear vision and manages myopia simultaneously.

Published scientific studies:

Defocus Incorporated Multiple Segments (DIMS) spectacle lenses slow myopia progression: a 2-year randomized clinical trial. (Published 11 Dec. 2019)

read article

Myopia control effect of Defocus Incorporated Multiple Segments (DIMS) spectacle lens in Chinese children: results of a 3-year follow-up study. (Published Online First: 17 March 2021)

read article

Long-term myopia control effect and safety in children wearing DIMS spectacle lenses for 6 years. (Published: 

Learn more

Testimonials

“Everyone involved in eyecare should be excited about Myopia management and how we can help protect the sight of the next generation. We jumped into dispensing MiYOSMART. It is simple to dispense after the excellent accreditation training from HOYA. We have had minimal issues with non-tolerance to the lens with most wearers saying they are unaware of any major visual discomfort”

 Ian Curtis, Owner at Curtis Opticians

"I've been recommending and providing myopia management for a number of years now, but the lack of a proven spectacle lens option has always been a significant challenge for those kids and parents who don't feel comfortable taking the leap into contact lens wear. Since I've had access to MiYOSMART I've been able to help many more kids. We've had an amazing response from the kids who have all adapted to the lens with no problems. The biggest thing I think is that parents feel reassured that they are taking some positive action when it comes to their children's eyesight."

Stephen Carr, Optometrist and Owner at Summers Optical

Four children playing outside while wearing glasses

Designed to suit a child’s active life.

MiYOSMART spectacle lenses have an easy-to-clean specific anti-reflective, durable coating. With MiYOSMART's Eye Shield, young patients get the added assurance of an impact resistant material and UV protection.

Four children playing outside while wearing glasses

MiYOSMART Sun - Protect How They See the World

With MiYOSMART Sun, slowing of myopia progression and protection from intense sunlight come together.6-7†

MiYOSMART Sun spectacle lenses adopted D.I.M.S. Technology for effective myopia management and correction of myopic refractive error, while protecting from intense sunlight and increasing eye comfort.6-7

Just like MiYOSMART clear spectacle lenses, MiYOSMART sun spectacle lenses offer 100% protection from UV-A and UV-B,6* reducing the risk of long-term damage to the eye.

*As per EN ISO 8980-3:2013 and ANSI Z80.3-2015 Standards.

†Assuming photochromic spectacle lenses are used at all times or in addition to MiYOSMART clear spectacles lenses, or polarized spectacle lenses are used in addition to MiYOSMART clear spectacle lenses. Patients should always consult their Eye Care Professionals for treatment decisions and instructions for use.

Disclaimer: 

MiYOSMART has not been approved for myopia management in all countries, including the U.S., and is not currently available for sale in all countries, including the U.S.

 

References: 

1) Leung TW, et al. Comparison of Myopia Progression in Individuals Wearing Defocus Incorporated Multiple Segments (DIMS) Spectacle Lenses for Eight Years versus Shorter  Durations. Poster number A0113. Presented 6th May, ARVO 2025.

2) Determined using available published evidence of myopia management spectacle lenses as of May 2025.

3) Fulton J.M.,McCullough S.J.,Saunders K.J.,Richardson P., Logan N.S., Whayeb Y., Williamson P., Barr H., Nagra M., Pardhan S., Shah R., Vlasak N. Multi-Site Observational Study of Defocus Incorporated Multiple Segments (DIMS) spectacle lenses in UK children: 2-year results. IMC Conference Presentation (2024) https://www.hoyavision.com/visionary-knowlegde/blogs-and-article/conference-imc-2024/

4) Jong M, Jonas JB, Wolffsohn JS, et al. IMI 2021 Yearly Digest. Invest. Ophthalmol. Vis. Sci. 2021;62(5):7. https://doi.org/10.1167/iovs.62.5.7

5) Lam CSY, Tang WC, Tse DY, Lee RPK, Chun RKM, Hasegawa K, et al. Defocus Incorporated Multiple Segments (DIMS) spectacle lenses slow myopia progression: a 2-year randomised clinical trial. Br J Ophthalmol. 2020;104(3):363-8

6) HOYA data on file. Transmission, traffic light recognition, and UV blocking test for MiYOSMART clear and MiYOSMART sun spectacle lenses. 02/2023. Tests were conducted at room temperature (23°C).

7) HOYA data on file. PSF test on MiYOSMART clear and sun spectacle lenses. 06/2022.

*Brien Holden Vision Institute; 2 Shanghai Eye Disease Prevention and Treatment Center https://guidelines.brienholdenvision.org, accessed 16.08.1018.